• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从伊朗耳真菌病病例中分离的黑曲霉的种属鉴定和抗真菌药敏试验。

Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran.

机构信息

Department of Microbiology, Faculty of Science & Informatics, University of Szeged, Szeged, Hungary.

出版信息

Mycoses. 2012 Jul;55(4):333-8. doi: 10.1111/j.1439-0507.2011.02103.x. Epub 2011 Sep 7.

DOI:10.1111/j.1439-0507.2011.02103.x
PMID:21895787
Abstract

Black aspergilli are among the main causative agents of otomycosis worldwide. In this study, the species assignment of black aspergilli isolated from otomycosis cases in Iran was carried out using sequence analysis of part of the calmodulin gene. The results indicate that Aspergillus niger is not the only black Aspergillus species involved in otomycosis cases in Iran: Aspergillus awamori and Aspergillus tubingensis are also able to cause ear infections. Antifungal susceptibility tests were carried out against five antifungal drugs including amphotericin B, fluconazole, itraconazole, ketoconazole and terbinafine. All isolates were highly susceptible to terbinafine, while they exhibited moderate susceptibilities against amphotericin B, fluconazole and ketoconazole. Aspergillus niger and A. awamori were found to have higher minimal inhibitory concentrations for azoles than A. tubingensis, in accordance with previous findings.

摘要

黑曲霉是全球范围内引起耳真菌病的主要病原体之一。在这项研究中,通过对钙调蛋白基因部分序列的分析,对从伊朗耳真菌病病例中分离出的黑曲霉进行了种属鉴定。结果表明,黑曲霉并不是引起伊朗耳真菌病的唯一黑曲霉物种:棘孢曲霉和土曲霉也能够引起耳部感染。对包括两性霉素 B、氟康唑、伊曲康唑、酮康唑和特比萘芬在内的五种抗真菌药物进行了药敏试验。所有分离株均对特比萘芬高度敏感,而对两性霉素 B、氟康唑和酮康唑表现出中度敏感性。与之前的研究结果一致,棘孢曲霉和土曲霉对唑类药物的最小抑菌浓度高于烟曲霉。

相似文献

1
Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran.从伊朗耳真菌病病例中分离的黑曲霉的种属鉴定和抗真菌药敏试验。
Mycoses. 2012 Jul;55(4):333-8. doi: 10.1111/j.1439-0507.2011.02103.x. Epub 2011 Sep 7.
2
Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.从耳真菌病患者中分离的曲霉属 Nigri 节段菌株的种属鉴定和体外抗真菌药敏试验。
J Mycol Med. 2018 Jun;28(2):279-284. doi: 10.1016/j.mycmed.2018.02.003. Epub 2018 Mar 11.
3
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.韦氏曲霉;一种主要引起耳真菌病的病原体,来自伊朗的新流行病学和抗真菌药敏数据。
Microb Pathog. 2023 Aug;181:106180. doi: 10.1016/j.micpath.2023.106180. Epub 2023 May 29.
4
Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.匈牙利耳真菌病病例中黑色曲霉菌的分子鉴定及抗真菌药敏性
Mycopathologia. 2012 Aug;174(2):143-7. doi: 10.1007/s11046-012-9529-8. Epub 2012 Feb 23.
5
The Molecular Identification and Antifungal Susceptibilities of Aspergillus Species Causing Otomycosis in Tochigi, Japan.日本栃木县导致外耳炎的曲霉菌属种的分子鉴定和抗真菌药敏性
Mycopathologia. 2019 Feb;184(1):13-21. doi: 10.1007/s11046-018-0299-9. Epub 2018 Oct 5.
6
Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.从中国西部耳真菌病患者中分离出的曲霉菌的分子鉴定及体外抗真菌药敏试验。
Mycopathologia. 2020 Jun;185(3):527-535. doi: 10.1007/s11046-020-00448-7. Epub 2020 Apr 28.
7
In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.引起耳霉菌病的曲霉属真菌对两性霉素B、伏立康唑和伊曲康唑的体外药敏试验
Mycoses. 2007 Nov;50(6):447-50. doi: 10.1111/j.1439-0507.2007.01409.x.
8
Prevalence of otomycosis in Khouzestan Province, south-west Iran.伊朗西南部胡齐斯坦省耳真菌病的患病率
J Laryngol Otol. 2013 Jan;127(1):25-7. doi: 10.1017/S0022215112002277. Epub 2012 Nov 20.
9
Cryptic species and azole resistance in the Aspergillus niger complex.黑曲霉复合体中的隐秘种和唑类耐药性。
Antimicrob Agents Chemother. 2011 Oct;55(10):4802-9. doi: 10.1128/AAC.00304-11. Epub 2011 Jul 18.
10
Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.临床和环境来源的黑曲霉群分离株的物种分布及体外唑类药物敏感性
J Clin Microbiol. 2016 Sep;54(9):2365-72. doi: 10.1128/JCM.01075-16. Epub 2016 Jul 13.

引用本文的文献

1
Otomycosis: a systematic review and meta-analysis of prevalence and causative agents in the era of molecular diagnostics.耳霉菌病:分子诊断时代患病率及病原体的系统评价与荟萃分析
BMC Infect Dis. 2025 Apr 17;25(1):544. doi: 10.1186/s12879-025-10954-y.
2
Molecular Identification of Species, Antifungal Susceptibility, and Phenotypic Identification of Azole-Resistant Mutations in Cyp51A Gene Isolated from Xinjiang.新疆分离株的菌种分子鉴定、抗真菌药敏性及Cyp51A基因唑类耐药突变的表型鉴定
Infect Drug Resist. 2025 Apr 2;18:1699-1711. doi: 10.2147/IDR.S496489. eCollection 2025.
3
First documentation of Aspergillus welwitschiae in COVID-19-associated pulmonary aspergillosis in the Americas.
美洲地区首次记录到韦氏曲霉在新冠病毒相关肺曲霉病中的情况。
Rev Inst Med Trop Sao Paulo. 2025 Feb 7;67:e8. doi: 10.1590/S1678-9946202567008. eCollection 2025.
4
Reducing the number of accepted species in series .减少系列中可接受物种的数量。
Stud Mycol. 2022 Dec;102:95-132. doi: 10.3114/sim.2022.102.03. Epub 2022 Dec 19.
5
In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.体外联合特比萘芬与酮康唑治疗体外分离的高特比萘芬 MIC 值烟曲霉菌属致外耳道真菌病。
Mycopathologia. 2023 Apr;188(1-2):119-127. doi: 10.1007/s11046-022-00698-7. Epub 2022 Nov 30.
6
A Whole Genome Sequencing-Based Approach to Track down Genomic Variants in Itraconazole-Resistant Species of from Iran.一种基于全基因组测序的方法来追踪伊朗伊曲康唑耐药菌种中的基因组变异。
J Fungi (Basel). 2022 Oct 17;8(10):1091. doi: 10.3390/jof8101091.
7
Identification and in vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran.伊朗马什哈德地区由曲霉属引起的甲真菌病的病原体鉴定及体外抗真菌药敏试验。
Sci Rep. 2021 Mar 24;11(1):6808. doi: 10.1038/s41598-021-86038-z.
8
Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.从耳真菌病患者中分离出的酵母和霉菌的分子鉴定及抗真菌药敏试验。
Mycopathologia. 2021 May;186(2):245-257. doi: 10.1007/s11046-021-00537-1. Epub 2021 Mar 15.
9
Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.伊朗阿瓦士耳霉菌病病原体的抗真菌药敏谱
Curr Med Mycol. 2020 Jun;6(2):18-22. doi: 10.18502/CMM.6.2.2696.
10
The potency of luliconazole against clinical and environmental complex.卢立康唑对临床和环境菌株的抗菌活性。 (注:原英文表述不太完整准确,根据语境推测补充完整后翻译,正常应该是The potency of luliconazole against clinical and environmental isolates 之类的表述 )
Iran J Microbiol. 2019 Dec;11(6):510-519.